ISSAR Pharma announces out-licensing of its peptide-based NCEs
ISSAR has several patents for peptide molecules lined up in their development pipeline targeting therapeutic areas such as…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
new chemical entities
Suven Life Sciences secures two product patents in Australia and Canada
The patents correspond to the NCEs for the treatment of disorders associated with neurodegenerative diseases Suven Life Sciences…
Suven Life Sciences secures five product patents
The granted claims of the patents from China, Israel, Mexico, Singapore, Sri Lanka include the class of selective 5-HT compounds…